Last reviewed · How we verify

NCT06941285

Montreal Cognitive Assessment Index Following MRI Guided Focused Ultrasound Thalamotomy

Completed Last updated 23 April 2025
What this trial tests

trial testing Data collection in Essential Tremor in 142 participants. Completed in 1 June 2024.

Timeline
1 November 2013
Primary endpoint
1 June 2024
1 June 2024

Quick facts

Lead sponsorRambam Health Care Campus
StatusCompleted
Study typeOBSERVATIONAL
Enrollment142
Start date1 November 2013
Primary completion1 June 2024
Estimated completion1 June 2024

Drugs / interventions tested

Conditions studied

Sponsor

Rambam Health Care Campus — full company profile →

Who can join

Eligibility, any sex, with Essential Tremor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We assessed Montreal Cognitive Assessment scores before and after MRI guided focused ultrasound thalamotomy for tremor in order to identify if there are changes in cognitive function following treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Data collection

Trials testing the same drug.

Other recruiting trials for Essential Tremor

Currently open trials in the same condition.

Other Rambam Health Care Campus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06941285.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing